Clinical data | |
---|---|
Trade names | Technescan Mag3 |
License data | |
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
KEGG |
Technetium (99mTc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys. [1] It is a renal imaging agent that is given by intravenous injection. [1]
It was approved for medical use in the United States in June 1990. [2]
Technetium (99mTc) mertiatide is indicated for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi. [1]
The active ingredient, betiatide, is reconstituted with sodium pertechnetate 99mTc injection to form technetium (99mTc) mertiatide. [1]